X
API Suppliers
US DMFs Filed
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
Annual Reports
0
0
https://www.pharmaceutical-technology.com/news/fda-radius-tymlos-osteoporosis/
https://www.globenewswire.com/news-release/2022/06/01/2454734/31149/en/Radius-Health-Update-on-Abaloparatide-Transdermal-System.html
https://www.globenewswire.com/news-release/2021/12/23/2357391/31149/en/Radius-Announces-Update-on-TYMLOS-abaloparatide-Label.html
https://www.globenewswire.com/news-release/2021/12/23/2357391/31149/en/Radius-Announces-Update-on-TYMLOS-abaloparatide-Label.html
https://www.globenewswire.com/news-release/2021/10/18/2315688/31149/en/Radius-Announces-Positive-Phase-3-Topline-Results-for-TYMLOS-abaloparatide-Subcutaneous-Injection-in-Males-with-Osteoporosis.html
https://www.prnewswire.com/news-releases/endo-announces-licensing-agreement-for-paladin-labs-inc-to-commercialize-abaloparatide-in-canada-301201070.html#:~:text=All%20Products-,Endo%20Announces%20Licensing%20Agreement%20for%20Paladin%20Labs,to%20Commercialize%20Abaloparatide%20in%20Canada&text=DUBLIN%2C%20Jan.%205%2C%202021,agreements%20with%20Radius%20Health%2C%20Inc.
https://ir.radiuspharm.com/news-releases/news-release-details/radius-health-enrollment-completed-phase-3-wearable-trial#:~:text=%2C%20Sept.%2008%2C%202020%20(,%E2%80%9CwearABLe%E2%80%9D%20phase%203%20trial.&text=%E2%80%9CWe%20are%20delighted%20to%20have,%2C%20Radius'%20Chief%20Medical%20Officer.
https://www.globenewswire.com/news-release/2020/05/27/2039144/0/en/Pivotal-Phase-III-trial-of-abaloparatide-SC-in-Japanese-women-and-men-with-osteoporosis-achieves-primary-endpoint.html
https://www.raps.org/news-and-articles/news-articles/2019/6/emas-chmp-rejects-another-drug-approved-by-us-fda
https://endpts.com/amgen-prices-bone-builder-evenity-at-21900-year-to-compete-on-convenience-not-cost/
https://www.ema.europa.eu/documents/smop-initial/questions-answers-refusal-marketing-authorisation-eladynos-abaloparatide_en.pdf
https://www.raps.org/news-and-articles/news-articles/2018/3/ema%E2%80%99s-chmp-rejects-two-drugs-approved-by-us-fda-in
http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2018/03/news_detail_002925.jsp&mid=WC0b01ac058004d5c1
http://www.raps.org/Regulatory-Focus/News/2017/04/12/27333/Fast-Start-for-FDA-Drug-Approvals-in-2017/?utm_source=Email&utm_medium=Informz&utm_campaign=Informz-Emails
http://www.bloomberg.com/news/articles/2015-11-17/radius-ceo-says-drug-application-delayed-for-work-life-balance-
Market Place
Share 
